Health House International Limited announced it has signed a 5 year exclusive distribution agreement (Distribution Agreement) with Zelira Therapeutics Ltd. (Zelira) in the United Kingdom (UK) subject to certain performance criteria. The Distribution Agreement will further expand Health House's product portfolio for cannabis products within the United Kingdom, adding the Zelira CBD toothpaste brand manufactured by Springjene in the United States of America, which represents a unique product offering in Oral Healthcare. The Distribution Agreement expands Health House's current portfolio of Zelira's products which includes the non-exclusive rights to distribute ZenivolTM and the HOPETM range of products throughout Australasia (including Australia, New Zealand and Asia) and the UK.